Previous Close | 0.1300 |
Open | 0.1200 |
Bid | 0.1209 x 0 |
Ask | 0.1350 x 0 |
Day's Range | 0.1200 - 0.1200 |
52 Week Range | 0.0007 - 0.8000 |
Volume | |
Avg. Volume | 41,033 |
Market Cap | 364,460 |
Beta (5Y Monthly) | -0.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.5100 |
Earnings Date | Jul 26, 2024 - Aug 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Processed by PBIO’s Patented UltraShear Technology, this Revolutionary Product Combines Leading Potency Oil-Based Antioxidants (e.g., Acai, Curcumin, Astaxanthin, CoQ10, & More) into a Super-Fast Absorbing, Highly Bioavailable, Nanoemulsified Oral Spray for Market-Leading PerformanceCANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broa
NOTE CHANGE IN DATE OF UPDATE CALL TO THURSDAY JUNE 20thCANTON, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Thursday, June 20, 2024 at 4:30pm ET. Topics to be discussed include: FY 2023 financial and business results.FY 2024 financial
CANTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics. The teleconference is scheduled for Wednesday, June 19, 2024 at 4:30 PM ET. The topics to be discussed include but are not limited to:FY 2023 financial and business results.FY 2024 financial and business outlook.Status